The direct administration of anti-inflammatory drugs into joints to provide relief from discomfort remains a common practice in many sectors of the equine industry. Unfortunately, many of these medications are corticosteroids, which have become c …

In May 1998, the U.S. Food and Drug Administration (FDA) approved the use of a branded version of clenbuterol for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD). In other …